Results 21 to 30 of about 169,886 (331)
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
Endocrine Connections, 2022 Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied.
Mark J C van Treijen +4 more
doaj +1 more source
BMC Gastroenterology, 2020 Background NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnosis and identification of residual disease. We independently assessed utility of the NETest to diagnose gastric neuroendocrine neoplasms (GNENs) and ...
A. Malczewska +6 more
doaj +1 more source
The influence of surgery quality on the longtime results of gastric cancer combination therapy
Nowotwory, 2022 INTRODUCTION: The aim of this study was to analyze the influence of surgical center experience on the long term survival of patients with locoregionally advanced gastric adenocarcinoma undergoing primary surgery, followed by complementary ...
Ireneusz Pierzankowski +4 more
doaj +1 more source
Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. [PDF]
, 2016 Neuroendocrine tumors (NETs) are grouped together as a single class on the basis of histologic appearance, immunoreactivity for the neuroendocrine markers chromogranin A and synaptophysin, and potential secretion of hormones, neurotransmitters ...
Brzezniak, Christina +11 more
core +10 more sources
Risk of malignancy in adrenal tumors in patients with a history of cancer
Frontiers in Oncology, 2023 PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel +11 more
doaj +1 more source
Updates on medical treatment for neuroendocrine neoplasm [PDF]
Zhongguo aizheng zazhi, 2022 Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine ...
LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie
doaj +1 more source
Duodenal carcinoid tumour – a case report [PDF]
, 2020 Duodenal carcinoids are rare tumours of the small intestine with heterogenous clinical and pathological characteristics. The long-term prognosis is very good if discovered in the early stages.
Alexescu, Teodora Gabriela +7 more
core +2 more sources
Updates on precision medicine of pancreatic neuroendocrine tumor [PDF]
Zhongguo aizheng zazhi, 2023 Since the concept of precision medicine proposed in 2011, the treatment of solid tumors has entered era of precision medicine led by gene testing. As a rare tumor, the incidence rate of pancreatic neuroendocrine tumor (PanNET) is increasing gradually. In
GAO Heli, XU Jin, CHEN Jie, YU Xianjun
doaj +1 more source
BMC Cancer, 2020 Background There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR).
Espen Thiis-Evensen +3 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundTumor grade determined by the Ki67 index is the best prognostic factor for pancreatic neuroendocrine tumors (PanNETs). However, we often observe that the grade of metastases differs from that of their primary tumors.
Wu-Hu Zhang +60 more
doaj +1 more source